Detalles de la búsqueda
1.
Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors.
Int J Mol Sci
; 24(6)2023 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36982802
2.
Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients.
Int J Mol Sci
; 22(17)2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34502204
3.
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.
Cancers (Basel)
; 15(13)2023 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444579
4.
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs.
Blood Adv
; 6(17): 5171-5183, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802458
5.
Second versus first wave of COVID-19 in patients with MPN.
Leukemia
; 36(3): 897-900, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35064223
6.
Breakthrough infections in MPN-COVID vaccinated patients.
Blood Cancer J
; 12(11): 154, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379921
Resultados
1 -
6
de 6
1
Próxima >
>>